Jump to section
Hyperfine's mission is to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging and data solutions.
Hyperfine has received massive plaudits for creating Swoop, the world's first FDA-cleared portable MRI system. Swoop leverages AI technology which allows tests to be conducted quickly at the point of care.
The company was founded by Jonathan Rothberg – a serial health tech entrepreneur and winner of the National Medal of Technology and Innovation, who has founded companies like AI-driven retina scanner Tesseract Health, and DNA sequencing company Quantum-Si.
Since launching in 2014, the company has expanded into Canada, and it went public in 2021. It has also secured a number of high-profile partnerships over the years: such as with Viz AI, that helped to upgrade the functionality of its imaging system; and more recently with the International Society for Magnetic Resonance in Medicine, a collaboration designed to extend global access to MR education.
In 2023, Swoop received CE Marking, meaning that it complies with safety and performance requirements in the EU, which opens the door for expansion into the EEA in the future. It also secured a grant to expand its research into low and middle-income countries, where it will investigate the effects of childhood malnutrition on school readiness and academic achievement.
Kirsty
Company Specialist at Welcome to the Jungle
May 2023
$3m
GRANT
Feb 2021
$90m
SERIES D
This company has top investors
Jonathan Rothberg
(Chairman)Founder & chairman of 4Catalyzer, which incubated Tesseract. Serial health entrepreneur who founded, among others, AI Therapeutics, DNA sequencing company Quantum-Si (IPO), and ultrasound company Butterfly Network. Awarded the National Medal of Technology and Innovation.